CASE CONTROL STUDY OF LEVETIRACETAM VS. FOSPHENYTOIN FOR SEIZURE PROPHYLAXIS IN CHILDREN RECEIVING BUSULFAN (BU) FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

被引：0
|
作者：
Skeens, M. A.
Soni, S.
Pai, V
Bajwa, R.
Pietryga, D.
Gross, T.
Termuhlen, A.
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation
    Soni, Sandeep
    Skeens, Micah
    Termuhlen, Amanda M.
    Bajwa, Rajinder P. S.
    Gross, Thomas G.
    Pai, Vinita
    PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 762 - 764
  • [2] A pilot study of levetiracetam (Keppra®) for seizure prophylaxis in children receiving IV busulfan for haematopoietic stem cell transplantation
    Soni, S.
    Skeens, M.
    Pai, V.
    Bajwa, R.
    Gross, T.
    Termuhlen, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S268 - S268
  • [3] Phenytoin Versus Levetiracetam for Busulfan-Induced Seizure Prophylaxis and Hematopoietic Stem Cell Transplantation Outcomes
    Farhan, Shatha
    Neme, Klodiana
    Mikulandric, Nancy
    Pelland, Danielle
    Wautelet, Susan
    Szymanski, Sarah
    Ruemenapp, Kenneth
    Trapp, Mary Ann
    Peres, Edward
    Janakiraman, Nalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S221 - S221
  • [4] Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning
    Germeraad, R. S.
    Demandt, A. M. P.
    Rouhl, R. P. W.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [5] Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation
    Shin-ichi Tsujimoto
    Ryota Shirai
    Tomoyuki Utano
    Tomoo Osumi
    Kana Matsumoto
    Yoko Shioda
    Chikako Kiyotani
    Toru Uchiyama
    Takao Deguchi
    Keita Terashima
    Daisuke Tomizawa
    Kimikazu Matsumoto
    Motohiro Kato
    International Journal of Hematology, 2020, 111 : 463 - 466
  • [6] Comparison of clonazepam and levetiracetam in children for prevention of busulfan-induced seizure in hematopoietic stem cell transplantation
    Tsujimoto, Shin-ichi
    Shirai, Ryota
    Utano, Tomoyuki
    Osumi, Tomoo
    Matsumoto, Kana
    Shioda, Yoko
    Kiyotani, Chikako
    Uchiyama, Toru
    Deguchi, Takao
    Terashima, Keita
    Tomizawa, Daisuke
    Matsumoto, Kimikazu
    Kato, Motohiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (03) : 463 - 466
  • [7] Improving dosing precision in busulfan(bu)-based preparative regimens for hematopoietic stem cell transplantation (HSCT).
    Nance, AG
    Teresi, WM
    Vaughan, WP
    McKay, JT
    Salzman, DE
    BLOOD, 2003, 102 (11) : 437B - 437B
  • [8] Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation
    Rambaran, Kerry Anne
    Seifert, Charles F.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 884 - 890
  • [9] The effect of liver cirrhosis on oral busulfan (BU) disposition in children suffering from thalassemia (TL) undergoing hematopoietic stem cell transplantation (HSCT).
    Elhasid, R.
    Hoffer, E.
    Lurie, Y.
    Bentur, Y.
    Krivoy, N.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1185 - 1185
  • [10] Association Between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation
    Ansari, Marc
    Theoret, Yves
    Rezgui, Mohamed Aziz
    Peters, Christina
    Mezziani, Samira
    Desjean, Catherine
    Vachon, Marie-France
    Champagne, Martin A.
    Duval, Michel
    Krajinovic, Maja
    Bittencourt, Henrique
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 93 - 99
12345